ADVANCED GENOMIC TECHNOLOGY, LLC

Medtech · Private

Blood biomarker tests detecting microRNA signatures to diagnose mild cognitive impairment and predict conversion to Alzheimer's disease

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$648K
Federal grants
$648K
1 award · 2015
Rank in peer group#24 of 95
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
6 pending · first 2016
Rank in peer group#14 of 95

Capital timeline

2015FEDERAL ↑EQUITY ↓Cumulative $648K$648K
2015FEDERAL ↑EQUITY ↓Cumulative $648K$648K

Latest events

  • Federal grantHealth and Human S · Phase II · Circulating Blood-Based Diagnostic for Mild Cognitive Impaired Victims$648K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 95 peers

Line = median

Medtech · Instrument

  • Federal grants#24 · top 25%
  • Granted patents#14 · top 15%
  • Linked publications#2 · top 2%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 7
Show all 7 patent records
  • Systems For Biomarker DetectionJan 3, 2019 · Application 16031254Pending
  • Transgenic mice expressing microRNA34 that have cells displaying increased senescence and apoptosisAug 2, 2016 · US 9,402,376Granted
  • Systems For Biomarker DetectionApr 14, 2016 · Application 14867459Pending
  • Biomarker For Alzheimer's Disease And/or Mild Cognitively Impairment, And Use ThereofApplication PCTUS2012049971Pending
  • Circulating Biomarkers For Alzheimer's Disease And/or Mild Cognitive ImpairmentApplication PCTUS2014058169Pending
  • Systems And Methods For Determining Likelihood Of Alzheimer's Disease And/or Mild Cognitive Impairment Status In A PatientApplication PCTUS2017022947Pending
  • Transgeneic Non-human Animal Model For Accelerated Aging And/or Age-related Symptom, And Use ThereofApplication PCTUS2013021165Pending

Recent research by its founders

  • OR12-01 Blocking The Maladaptive Integrated Stress Response Increases Immunosuppressive PD-L1 In Pancreatic β-Cells20230 cites
  • Growth Control During Cell Aging202039 cites
  • Programmed Gene Expressions Suggest Multiple Blocks to Replication During Cell Aging20200 cites
  • NanoxSimilar federal contract value in Medtech · null in contracts
  • LEBRUN LABS, LLCSimilar federal contract value in Medtech · null in contracts
  • BIOSENSING INSTRUMENT, INC.Similar federal contract value in Medtech · null in contracts
  • PLUMERIA THERAPEUTICS, INC.Similar federal contract value in Medtech · null in contracts
  • CACTUS MEDICAL,LLCSimilar federal contract value in Medtech · null in contracts
  • Delfi DiagnosticsSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .